These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8673714)

  • 41. Vascular anatomy and disorders of the lumbar spine and spinal cord.
    Bowen BC; Pattany PM
    Magn Reson Imaging Clin N Am; 1999 Aug; 7(3):555-71. PubMed ID: 10494535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions.
    Do RK; Rusinek H; Taouli B
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):339-49. PubMed ID: 19406362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver MR imaging: 1.5T versus 3T.
    Ramalho M; Altun E; Herédia V; Zapparoli M; Semelka R
    Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):321-47, vi. PubMed ID: 17893053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MR imaging of the small bowel in Crohn's disease.
    Siddiki H; Fidler J
    Eur J Radiol; 2009 Mar; 69(3):409-17. PubMed ID: 19118967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasmall iron oxide particle contrast agent and MRI can be used to monitor the effect of anti-rejection treatment.
    Penno E; Johansson L; Ahlström H; Johnsson C
    Transplantation; 2007 Aug; 84(3):374-9. PubMed ID: 17700163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions.
    Wesbey GE; Brasch RC; Engelstad BL; Moss AA; Crooks LE; Brito AC
    Radiology; 1983 Oct; 149(1):175-80. PubMed ID: 6611926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Possibilities of proton spin tomography (MRI) in the gastrointestinal tract].
    Rohr G; Henrich D; Hoepfel D; Singer MV
    Z Gastroenterol; 1991 May; 29(5):267-9. PubMed ID: 1950037
    [No Abstract]   [Full Text] [Related]  

  • 48. Advances in contrast-enhanced MR imaging. Gastrointestinal contrast agents.
    Hahn PF
    AJR Am J Roentgenol; 1991 Feb; 156(2):252-4. PubMed ID: 1898795
    [No Abstract]   [Full Text] [Related]  

  • 49. Current and emerging techniques in gastrointestinal imaging.
    McSweeney SE; O'Donoghue PM; Jhaveri K
    J Postgrad Med; 2010; 56(2):109-16. PubMed ID: 20622390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans.
    Mattrey RF; Hajek PC; Gylys-Morin VM; Baker LL; Martin J; Long DC; Long DM
    AJR Am J Roentgenol; 1987 Jun; 148(6):1259-63. PubMed ID: 3495156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New concepts in imaging of the gastrointestinal tract in children.
    Babyn PS; Stringer DA
    Semin Pediatr Surg; 1992 Nov; 1(4):277-83. PubMed ID: 1345496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MR contrast agents: an overview.
    Gibby WA
    Radiol Clin North Am; 1988 Sep; 26(5):1047-58. PubMed ID: 3047775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Technical note: dynamic analysis of the pharynx during swallowing using Turbo-FLASH magnetic resonance imaging combined with an oral positive contrast agent--a preliminary study.
    Suto Y; Kamba M; Kato T
    Br J Radiol; 1995 Oct; 68(814):1099-102. PubMed ID: 7496712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetic resonance contrast agents for medical and molecular imaging.
    Allen MJ; Meade TJ
    Met Ions Biol Syst; 2004; 42():1-38. PubMed ID: 15206098
    [No Abstract]   [Full Text] [Related]  

  • 55. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.
    Wesbey GE; Brasch RC; Goldberg HI; Engelstad BL; Moss AA
    Magn Reson Imaging; 1985; 3(1):57-64. PubMed ID: 3923293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent.
    Unger EC; Fritz TA; Palestrant D; Meakem TJ; Granstrom P; Gatenby RA
    J Magn Reson Imaging; 1993; 3(1):119-24. PubMed ID: 8428077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ferrite particles as an MR contrast agent.
    Saini S; Ferrucci JT
    Radiology; 1988 Dec; 169(3):656. PubMed ID: 3186987
    [No Abstract]   [Full Text] [Related]  

  • 58. Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging.
    Mattrey RF
    AJR Am J Roentgenol; 1989 Feb; 152(2):247-52. PubMed ID: 2643258
    [No Abstract]   [Full Text] [Related]  

  • 59. Rapid abdominal MR imaging.
    Mirowitz SA
    Magn Reson Imaging Clin N Am; 1995 Feb; 3(1):1-12. PubMed ID: 7767739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Magnetic resonance imaging. Sequences, options, indications].
    Duewell S; von Schulthess GK; Fuchs WA
    Radiologe; 1993 Feb; 33(2):64-74. PubMed ID: 8469756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.